The identification of suitable tumour-specific antigens, which can be targeted by vaccine-based or T cell-based immunotherapies, is challenging. This Review explores the potential of alternative splicing to generate unique tumour antigens and discusses methods for their identification.
- Luke Frankiw
- David Baltimore
- Guideng Li
